Aphios Corporation, Woburn, MA, and ITC/Immune Technology, San Jose, CA, have collaborated to develop, manufacture and commercialize a natural therapeutic for hepatitis C patients. Under the agreement, Aphios and ITC will pool their scientific resources and intellectual property and share all costs and revenues associated with research, development and marketing of the natural hepatitis C therapeutic.